Vargas-Toscano, A., Nickel, A., Li, G., Kamp, M. A., Muhammad, S., Leprivier, G., . . . Kahlert, U. D. (2020). Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically with Tumor Treating Fields to Reduce Resistance against Temozolomide. Cancers (Basel).
Chicago Stili AlıntıVargas-Toscano, Andres, et al. "Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically With Tumor Treating Fields to Reduce Resistance against Temozolomide." Cancers (Basel) 2020.
MLA AlıntıVargas-Toscano, Andres, et al. "Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically With Tumor Treating Fields to Reduce Resistance against Temozolomide." Cancers (Basel) 2020.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..